PREDICTORS OF MEAN PHENYLALANINE LEVELS DURING THE FIRST 5 YEARS OF LIFE IN PATIENTS WITH PHENYLKETONURIA WHO WERE TREATED EARLY

被引:2
|
作者
VERKERK, PH
VANSPRONSEN, FJ
VANHOUTEN, M
SMIT, GPA
SENGERS, RCA
机构
[1] UNIV GRONINGEN HOSP,BEATRIX PEDIAT CLIN,GRONINGEN,NETHERLANDS
[2] UNIV NIJMEGEN HOSP,DEPT PEDIAT,NIJMEGEN,NETHERLANDS
关键词
D O I
10.1111/j.1651-2227.1994.tb13456.x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
We studied the relationship between plasma phenylalanine level at first diagnostic visit, country of origin of the mother, birth cohort, child clinic, sex, and social class on the one hand and mean plasma phenylalanine levels in the first five years of life on the other hand in patients with phenylketonuria (PKU) who were treated early. The study population consisted of 131 early treated patients with PKU born during the period from September 1st, 1974 to December 31st, 1988 in The Netherlands. Plasma phenylalanine levels from first diagnostic visit (usually before the age of three weeks) up until the fifth birthday were registered. For each patient the mean phenylalanine level during that period was calculated. Our results suggest that 1) it is more difficult to maintain low phenylalamine levels in patients with a more severe form of PKU, 2) in recent years paediatricians have treated their patients with a stricter diet, 3) there are differences in perception between paediatricians of different clinics as to what levels are acceptable, and 4) treatment of patients from non-Dutch mothers is more difficult than treatment of patients with Dutch mothers.
引用
收藏
页码:70 / 72
页数:3
相关论文
共 23 条
  • [21] BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria
    Branford, Susan
    Seymour, John F.
    Grigg, Andrew
    Arthur, Chris
    Rudzki, Zbigniew
    Lynch, Kevin
    Hughes, Timothy
    [J]. CLINICAL CANCER RESEARCH, 2007, 13 (23) : 7080 - 7085
  • [22] rospective Study of Aromatase Inhibitor Induced Bone Loss and Lipid Levels in Early Postmenopausal (PM) Hormone Receptor Positive (HR plus ) Breast Cancer (BC) Patients Treated with Adjuvant Letrozole Extended beyond 5 Years (yrs).
    Fontaine, C.
    Hanssens, S.
    Van Den Berge, D.
    Decoster, L.
    Schallier, D.
    Declippeleir, D.
    Vanhoeij, M.
    Lamote, J.
    Sacre, R.
    De Greve, J.
    [J]. CANCER RESEARCH, 2011, 71
  • [23] BASELINE LEVELS OF CTX-II AND GLUCOSYL-GALACTOSYL-PYRIDINOLINE IN PATIENTS WIH EARLY PSORIASIC ARTHRITIS: ASSOCIATION WITH DISEASE SEVERITY, DISABILITY, QUALITY-OF-LIFE, BIOLOGICAL TREATMENT REQUIRED AND PROGRESSION OF JOINT DESTRUCTION AT 5 YEARS OF FOLLOW UP
    Trujillo, E.
    Garcia, M.
    Sanchez, H.
    Exposito, L.
    Monroy, A.
    Trujillo, M. D. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1153 - 1154